Table 1
Study group of 100 patientsPercentage Change in BMD
Treatment GroupNGenderAge rangeBS*BH**
MalesFemaleYearsAfter 1 yrAfter 2 yrsAfter 1 yrAfter 2 yrs
ZA - Zoledronic Acid50123842–792.192.770.022.47
PTH -Teriparatide50104040–754.651X2.272X
LSC - Least Significant Change for single DXA machine2.50%3.60%
  • *Average of L2,3,4 Spine; **Total Hip.